Medicare Enrolled

Dr. Thomas Aung, M.D.

Medical Oncology · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
12201 RENFERT WAY, Austin, TX 78758
5128738900
In practice since 2006 (19 years)
NPI: 1679515530 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aung from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aung? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aung

Dr. Thomas Aung is a medical oncology specialist in Austin, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aung performed 7,706 Medicare services across 355 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aung received a total of $2,508 from 31 pharmaceutical and/or device companies across 157 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aung is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 42% volume in TX $2,508 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,706
Medicare services
Top 42% in TX for medical oncology
355
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~406 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 6,900 $0 $2
Dexamethasone injection (steroid) 309 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 130 $1 $114
Administration of chemotherapy into vein, 1 hour or less 50 $100 $707
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 47 $22 $157
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 46 $49 $313
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 34 $284 $2,762
Injection of additional new drug or substance into vein 31 $12 $108
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 29 $16 $100
Infusion, normal saline solution , 1000 cc 20 $2 $19
Administration of additional new drug or substance into vein, 1 hour or less 19 $49 $344
Drug injection, under skin or into muscle 18 $11 $96
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 17 $56 $211
Injection, diphenhydramine hcl, up to 50 mg 16 $1 $7
Infusion into a vein for hydration, 31-60 minutes 15 $25 $256
Irrigation of implanted venous access drug delivery device 13 $19 $114
Unclassified drugs 12 $1 $9
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
97.0% medium
1.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,508
Total received (2018-2024)
Avg $418/year across 6 years
Bottom 42% in TX for medical oncology
31
Companies
157
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,247 (89.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$261 (10.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$21
2023
$19
2021
$32
2020
$137
2019
$1,120
2018
$1,178

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$323
E.R. Squibb & Sons, L.L.C.
$295
AstraZeneca Pharmaceuticals LP
$263
Alexion Pharmaceuticals, Inc.
$181
Amgen Inc.
$150
Genentech USA, Inc.
$114
Merck Sharp & Dohme Corporation
$109
PFIZER INC.
$104
Janssen Biotech, Inc.
$95
EISAI INC.
$81
Lilly USA, LLC
$79
Eisai Inc.
$67
Astellas Pharma US Inc
$66
GENZYME CORPORATION
$63
AMAG Pharmaceuticals, Inc.
$58
Verastem, Inc.
$57
Ipsen Biopharmaceuticals, Inc
$50
Takeda Pharmaceuticals U.S.A., Inc.
$45
Seattle Genetics, Inc.
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Bayer HealthCare Pharmaceuticals Inc.
$31
Incyte Corporation
$28
Taiho Oncology, Inc.
$27
Rigel Pharmaceuticals, Inc.
$26
Gilead Sciences, Inc.
$24
Jazz Pharmaceuticals Inc.
$23
SOBI, INC
$21
Abbott Laboratories
$16
Regeneron Healthcare Solutions, Inc.
$13
Dova Pharmaceuticals
$12
Pharmacyclics LLC, An AbbVie Company
$11
Top 3 companies account for 35.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Aliqopa · Aranesp · Avastin · Axium INS DRG IPG · CALQUENCE · CYRAMZA · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · EMEND · EMPLICITI · FERAHEME · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MYLOTARG · NINLARO · Neulasta · Nplate · OPDIVO · PADCEV · PROMACTA · Perjeta · Prolia · RYDAPT · SANDOSTATIN · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · Soliris · Somatuline Depot · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · Tavalisse · VYXEOS · XOSPATA · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $33 per 100 Medicare services performed
Looking for a medical oncology specialist in Austin?
Compare medical oncologists in the Austin area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
28
Per 100K population
2.1
County median income
$97,169
Nearest hospital
NORTH AUSTIN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Aung is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Aung experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Aung performed 6,900 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aung receive payments from pharmaceutical companies?
Yes. Dr. Aung received a total of $2,508 from 31 companies across 157 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aung's costs compare to other medical oncologists in Austin?
Dr. Aung's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aung) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →